Diabetes Mellitus 2 Type Clinical Trial
Official title:
Comparison of Modern Premixed Insulin and Basal-Bolus Regimens on Blood Glucose Control Using CGMS Device in Optimally-controlled Subjects With DM2.
Intensive Insulin Therapy (IIT) may be given in Type 2 Diabetes (T2DM) in two different ways
:
- as Basal/bolus therapy (B/B) in four-five injections per day .
- as Modern Premixed Insulins( MPI's) three times per day . The better diabetes control
is achieved, the more likely patient would suffer from hypoglycemic episodes. We
propose that the probability of hypoglycemia and its severity has no difference in two
main insulin therapy schemes mentioned above.
The objective of the study is to compare the incidence of hypoglycemia and its severity in
well-controlled ( HBA1C less than 7%) diabetic individuals treated by two different
regimens, through analysis of data received by Continuous Glucose Monitoring (CGM, Free
Style Navigator).
n/a
Observational Model: Cohort, Time Perspective: Prospective